NCT05433623

Brief Summary

Creating a 12 month profile of Vascular Surgery Admissions aims to inform service delivery and optimise patient care resources. There is a gap in the literature pertaining to this topic, particularly from an Irish perspective. This research could inform a clinical pathway to reduce LOS for patients cared for by the Department of Vascular Surgery.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2025

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 1, 2022

Completed
26 days until next milestone

First Posted

Study publicly available on registry

June 27, 2022

Completed
3.2 years until next milestone

Study Start

First participant enrolled

September 15, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
Last Updated

September 18, 2025

Status Verified

September 1, 2025

Enrollment Period

Same day

First QC Date

June 1, 2022

Last Update Submit

September 12, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Clinical Frailty Scale

    Clinical frailty score will be determined for vascular patient admissions. This is a 9 point scale. the higher the score means the greater the risk.

    1 year

  • Charlson Co-Morbidity Scale

    Scoring will be determined for vascular patient admissions. The Charlson Comorbidity Index (CCI) assesses comorbidity level by taking into account both the number and severity of 19 pre-defined comorbid conditions. It provides a weighted score of a client's comorbidities which can be used to predict short term and long-term outcomes such as function, hospital length of stay and mortality rates.

    1 year

  • Admission details

    Length of stay, interventions, referral source will be documented

    1 year

Study Arms (1)

Vascular Surgery Admissions

Patients who present and/or are admitted to University Hospital Limerick under the care of a Vascular Consultant.

Procedure: Surgery

Interventions

SurgeryPROCEDURE

It will be documented if the patient underwent surgery for their vascular issue

Vascular Surgery Admissions

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study aims to create a profile f vascular admissions to a tertiary care hospital in the Mid West of Ireland and describe the characteristics of the admission.

You may qualify if:

  • Patients attending UHL deemed to have vascular care needs and assigned to the care of a Vascular Consultant will be included in this study.
  • The data will be collected 12 months from the date of commencing the study.

You may not qualify if:

  • Patients outside of the set dates will be excluded.
  • Vascular consults will be excluded for the purpose of this research unless care is transferred.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Vascular Diseases

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Cardiovascular Diseases
0

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Nurse Manager

Study Record Dates

First Submitted

June 1, 2022

First Posted

June 27, 2022

Study Start

September 15, 2025

Primary Completion

September 15, 2025

Study Completion

September 15, 2025

Last Updated

September 18, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

The researcher will not be sharing IPD